NEPG(SZ:000597) Zheng Quan Zhi Xing·2025-09-07 09:15Core Viewpoint - Northeast Pharmaceutical Group Co., Ltd. has appointed Ms. Li Xin as the new Chief Financial Officer, effective from the date of the board meeting on September 6, 2025, until the next board election [1]. Group 1: Appointment Details - The appointment was made based on the company's development needs and was approved by the board after a nomination and qualification review process [1]. - Ms. Li Xin will replace Mr. Cai Yonggang, who has been acting as the CFO [1]. Group 2: Ms. Li Xin's Background - Ms. Li Xin, born in 1980, holds a bachelor's degree and has extensive experience in finance, having previously served as the head of the finance department at several companies [2]. - She currently holds the position of Chairman of the Supervisory Board at Fangda Carbon New Material Technology Co., Ltd. and has no significant relationships with the company's directors, supervisors, or major shareholders [2]. - Ms. Li Xin meets the qualifications required by relevant laws and regulations, including the Company Law and the Shenzhen Stock Exchange listing rules [2].